BeStock  
Stocks › Biotechnology › DNLI

Denali Therapeutics DNLI

US equityMarket cap rank #2440Biotechnology
$18.45 +$0.25 (+1.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.45 0.00%
Open$17.97
Prev close$18.20
Day range$17.92 – $18.85
Volume2.63M
Market cap$2.96B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-10.9x
CheapRich

Below its usual level · 38th percentile, 5-year average -6.2x

Price / book3.2x
CheapRich

Around its usual level · 57th percentile, 5-year average 3.2x

#3866 of 5330 stocks by PB (1 = cheapest)

Price / sales140.5x
CheapRich

Around its usual level · 54th percentile, 5-year average 986.7x

#4981 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-38x13x63x114xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$23.21
Price vs. fair value-20.5%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.24 – 3.22 57% (pricier than usual) #3866 of 5330 (1 = cheapest)
PE -10.90 -6.71 -6.21 38% (cheaper than usual) –
PS 140.48 18.24 986.71 54% (pricier than usual) #4981 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on DNLI.

Sign in to join the discussion.

Scroll to Top